[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $nktr

Nektar Therapeutics (NKTR) sees significant social media buzz around potential acquisition by Eli Lilly, alongside positive clinical trial updates. However, ongoing legal battles and market volatility introduce critical concerns for investors.

### About $nktr
Nektar Therapeutics is a biotechnology company focused on developing innovative therapies.  

### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXXX  
X Week: XXXXXXX -XX%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXXX +873%  
X Year: XXXXXXXXXX +1,872%  
1-Year High: XXXXXXXXX on 2025-06-24  
1-Year Low: XX on 2024-12-19  

Engagements by network (24h):
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXX -XX%  
X Months: XXXXXX +3,657%  
X Year: XXXXXX +2,626%  
1-Year High: XXXXX on 2025-06-25  
1-Year Low: X on 2025-02-03  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $nktr in the last XX hours which is up XXXX% from XX in the previous XX hours
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXX -XX%  
X Months: XXXXXX +3,750%  
X Year: XXXXXX +3,489%  
1-Year High: XXXXX on 2025-06-25  
1-Year Low: X on 2025-02-01  

The most influential creators that mention $nktr in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)         | X    | XXXXXX    | X     | XXXXX       |
| [@seedy19tron](/creator/twitter/seedy19tron)       | X    | XXXXX     | X     | XXXXX       |
| [@doepke_michel](/creator/twitter/doepke_michel)   | X    | XXXXX     | X     | XXX         |
| [@stocket_rocket](/creator/twitter/stocket_rocket) | X    | XX        | X     | XX          |

[View More](/list/creators/$nktr/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -X%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2024-12-09  
1-Year Low: XX% on 2025-03-31  

Most Supportive Themes:
- Acquisition Rumors: (60%) Speculation surrounding a potential acquisition by Eli Lilly is driving significant interest and positive sentiment.
- Clinical Trial Data & Designations: (20%) Positive clinical trial data, including the FDA's Fast Track designation for Rezpegaldesleukin, is boosting confidence in the company's pipeline.
  
Most Critical Themes:
- Legal Proceedings & Market Volatility: (20%) Concerns persist regarding ongoing legal battles and general market fluctuations impacting the stock's stability.
  

### Top $nktr Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"#BTCUSD BUY NOW 89500 We are considering Buying $BTCUSD Target 1: 89700 Target 2: 89900 Target 3: 90100 Target 4: 90300 Target 5: 90600 SL 89200 $CRO $VVS $BTC $ETH $SOL $XRP $DOGE $SHIB $PEPE $PI $SUI $ADA $TRUMP $HBAR $nktr"  
[X Link](https://x.com/AFXJOON/status/1997237750849020089) [@AFXJOON](/creator/x/AFXJOON) 2025-12-06T09:32Z XX followers, XX engagements


"$NKTR assumptions: X. Settlement talks morphed into BO talks after P2b OX-40 demise X. AA adds $1-2B valuation no deal until data X. Co knows data since Q3 call. CLO leaves X. $Lly has to sign prior to +ve data X. If AA data next week imminent BO prob ; If not BO prob 📈"  
[X Link](https://x.com/Biolo_gic/status/1997140359588282399) [@Biolo_gic](/creator/x/Biolo_gic) 2025-12-06T03:05Z XXX followers, 6071 engagements


"Given all this $CDTX absurdity I lean towards the idea that $ABVX is closer to XXX than XXX FWIW. I believe today's shift in the options chain was pricing in this higher prem and absurd bidding war. All I ask is deal is finalized after $NKTR AA so I can get my shares in. Side note never be more than XX% options in a buyout play like this that's how you get burned Also remember this informational edge other's have is way greater than you can imagine"  
[X Link](https://x.com/HeikwanTrades/status/1997128964477686070) [@HeikwanTrades](/creator/x/HeikwanTrades) 2025-12-06T02:20Z XXX followers, 6382 engagements


"$nktr Le Duff paper has no weaknesses. Tregs significantly and peristently increased even months after end of treatment. SALT score was followed throughout entire trial and never improved even a bit. Issue wasnt washout period. Wish people would stop pumping AA POS"  
[X Link](https://x.com/cluelessbio/status/1997049282910683507) [@cluelessbio](/creator/x/cluelessbio) 2025-12-05T21:03Z XX followers, 1368 engagements